| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN | /s/ Vincent Fontanilla, Attorney-in-Fact | 2025-10-29 | 0001697362 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NTRA | Common Stock | Sale | -$150K | -781 | -1.13% | $192.32 | 68.4K | Oct 27, 2025 | Direct | F1 |
| transaction | NTRA | Common Stock | Sale | -$237K | -1.24K | -1.81% | $191.46 | 67.2K | Oct 28, 2025 | Direct | F2 |
| transaction | NTRA | Common Stock | Sale | -$109K | -574 | -0.85% | $189.90 | 66.6K | Oct 28, 2025 | Direct | F3, F4 |
| transaction | NTRA | Common Stock | Sale | -$77.4K | -404 | -0.61% | $191.51 | 66.2K | Oct 28, 2025 | Direct | F3, F5 |
| transaction | NTRA | Common Stock | Sale | -$38.4K | -200 | -0.3% | $192.20 | 66K | Oct 28, 2025 | Direct | F3, F6 |
| transaction | NTRA | Common Stock | Sale | -$56.5K | -300 | -0.45% | $188.37 | 65.7K | Oct 29, 2025 | Direct | F3, F7 |
| transaction | NTRA | Common Stock | Sale | -$76K | -400 | -0.61% | $189.91 | 65.3K | Oct 29, 2025 | Direct | F3, F8 |
| transaction | NTRA | Common Stock | Sale | -$127K | -667 | -1.02% | $190.99 | 64.6K | Oct 29, 2025 | Direct | F3, F9 |
| transaction | NTRA | Common Stock | Sale | -$96.1K | -500 | -0.77% | $192.12 | 64.1K | Oct 29, 2025 | Direct | F3, F10 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 26, 2024. |
| F2 | The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023. |
| F3 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. |
| F4 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.49 to 190.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.88 to $191.80 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.93 to $192.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.06 to $189.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F8 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.24 to $190.05 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F9 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.42 to $191.41 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F10 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.98 to $192.29 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |